Clinical Significance of IGFBP-3 Methylation in Patients with Early Stage Gastric Cancer Seung Tae Kim, Hye-Lim Jang, Jeeyun Lee, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Min Gew Choi, Jae Moon Bae, Tae Sung Sohn, Jae Hyung Noh, Sung Kim, Kyoung-Mee Kim, Won Ki Kang, Joon Oh Park Translational Oncology Volume 8, Issue 4, Pages 288-294 (August 2015) DOI: 10.1016/j.tranon.2015.06.001 Copyright © 2015 The Authors Terms and Conditions
Figure 1 IGFBP-3 methylation as measured by MS-PCR and MethyLight quantitativePCR in gastric cancer cell lines. Translational Oncology 2015 8, 288-294DOI: (10.1016/j.tranon.2015.06.001) Copyright © 2015 The Authors Terms and Conditions
Figure 2 Survival analysis: Disease-free (A) and overall (B) survival curves according to the status of IGFBP-3 methylation. Translational Oncology 2015 8, 288-294DOI: (10.1016/j.tranon.2015.06.001) Copyright © 2015 The Authors Terms and Conditions
Figure 3 Survival analysis: Disease-free (A, B) and overall (C, D) survival curves by gender according to methylation status. Translational Oncology 2015 8, 288-294DOI: (10.1016/j.tranon.2015.06.001) Copyright © 2015 The Authors Terms and Conditions